GOVX
GeoVax Labs Inc
NASDAQ: GOVX · HEALTHCARE · BIOTECHNOLOGY
$1.48
-7.82% today
Updated 2026-06-05
Market cap
$8.60M
P/E ratio
—
P/S ratio
10.09x
EPS (TTM)
$-13.82
Dividend yield
—
52W range
$1 – $35
Volume
6.1M
WallStSmart proprietary scores
13
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+5.3
Quality
C+2.5
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$10.00
+575.68%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-3.55M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $81000.00 | $0.00 | $3.95M | $2.49M | $852280.00 |
| Net income | $-14.01M | $-25.97M | $-24.99M | $-21.46M | $-5.26M |
| EPS | — | — | — | — | $-13.82 |
| Free cash flow | $-19.16M | $-25.22M | $-24.70M | $-21.50M | $-3.55M |
| Profit margin | -17,301.93% | — | -631.98% | -862.34% | — |
Peer comparison
Smart narrative
GeoVax Labs Inc trades at $1.48. Our Smart Value Score of 13/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $852280.00.
Frequently asked questions
What is GeoVax Labs Inc's stock price?
GeoVax Labs Inc (GOVX) trades at $1.48, on a P/S of 10.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is GeoVax Labs Inc overvalued?
GeoVax Labs Inc carries a Smart Value Score of 13/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of GeoVax Labs Inc (GOVX)?
The 12-month analyst consensus target is $10.00, about 575.7% above the current $1.48. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is GeoVax Labs Inc's revenue?
GeoVax Labs Inc's trailing twelve-month revenue is $852280.00. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio10.09x
ROE-509.00%
Beta3.35
50D MA$1.58
200D MA$7.31
Shares out0.01B
Float0.00B
Short ratio—
Avg volume6.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—